Adamant Health
Harri Hallila is a seasoned professional in the biomedical and healthcare sectors, holding multiple leadership roles since 2012. Currently serving as a Board Member at Adamant Health Oy and Askel Healthcare Ltd, and as Managing Director for both Globus Medical's International Advanced Technologies division and Synoste Oy, Harri Hallila oversees the development of innovative medical solutions, particularly for orthopedic applications. With a background that includes research roles at Invalidisäätiö, Aalto University, and as a Visiting Researcher at the University of Bern, Harri Hallila has contributed significantly to the field of orthopedic devices. Educational qualifications include a Master of Science in Technology from Teknillinen korkeakoulu-Tekniska högskolan and a Master of Science in Physics from ETH Zürich.
This person is not in the org chart
This person is not in any teams
Adamant Health
We are helping people with Parkinson's disease by providing an accurate and clear picture of their condition to get the best treatment possible, improving their quality of life. Adamant Health is a Finnish health-tech startup on a mission to revolutionize the care of Parkinson’s disease by enabling data-driven disease management, supporting earlier diagnosis and improving patient outcomes. The company was founded in 2020 as a spin-off from the University of Eastern Finland to bring our research-based, innovative technology to patients, clinicians, healthcare service providers and companies developing new therapies. We have developed the first, advanced precision technology able to measure the visible and invisible motor symptoms of Parkinson's disease. Our unique CE-marked data-analysis technology, based on surface electromyography (EMG) and motion measurement, provides detailed and accurate symptom data, essential for supporting personalized treatment that can be continuously optimized. Our technology is based on over 15 years of research with more than 25 scientific articles published in international publications. In addition to Parkinson's disease, our technology brings also visibility to the symptoms of various other movement disorders.